Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Muscle Weakness; Myasthenia Gravis | Phase 2 | ClinicalTrials |
| Hemolysis | Phase 2 | ClinicalTrials |
| Muscle Weakness; Myasthenia Gravis | Phase 2 | ClinicalTrials |
CONTENTS
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Muscle Weakness; Myasthenia Gravis | Phase 2 | ClinicalTrials |
| Hemolysis | Phase 2 | ClinicalTrials |
| Muscle Weakness; Myasthenia Gravis | Phase 2 | ClinicalTrials |